Company Overview

Business Description

Headquarters
Canada CA
IPO date
May 15, 2018

Clearmind Medicine, Inc. operates as a mineral resource company, which acquires, explores, develops, and operates mineral resource assets in Canada. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2018-05-15. The firm is focused on the discovery and development of novel psychedelic derived therapeutics to solve health problems including alcohol use disorder. The firm is engaged in the research and development of compounds derived from psychedelics and commercializes them as regulated medicines, foods, or supplements. The firm's portfolio consists of patent families such as binge behavior regulators and alcoholic beverage substitutes.

Clearmind Medicine Inc Investor Relations

Address
905 - 1030 West Georgia Street
Vancouver, British Columbia
Canada
Contacts

Management

Dr. Adi Zuloff-Shani Ph.D.

Chief Executive Officer

Biography unavailable

Mr. Alan Mark Rootenberg B.Com., B.Comm, C.A., CPA

Chief Financial Officer

Biography unavailable

Prof. Mark Haden

Vice President of Business Development

Biography unavailable

Mr. Gilad Babchuk

Head of Strategy & Communication

Biography unavailable

1 / 4